Observational clinical trial looks at multi-institutional registry for prostate cancer radiosurgery

Clinical trial demonstrates CyberKnife effectiveness for prostate cancer

ZeroCancer

A ZeroCancer news roundup highlights the latest clinical trial study following the Registry for Prostate Cancer Radiosurgery, launched in July 2010, which follows the overall treatment effectiveness of CyberKnife for prostate cancer. The Frontiers in Oncology study, which includes Anova Cancer Care patients, follows more than 2,700 men from 45 participating locations. The study reported that CyberKnife treatment was effective in treating prostate cancer as well as preserving sexual health with no significant side effects.

ZeroCancer news roundup

Frontiers in Oncology study

Ready to meet our cancer specialists?

Request an Appointment

About the Author: Anova Cancer Care

card image